Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer

World Journal of Surgery

Volumn 30, Issue 4, 2006, Pages 579-584

  De Manzoni, G ^a   Verlato, G ^a   Di Leo, A ^a   Tomezzoli, A ^b   Pedrazzani, C ^a   Pasini, F ^a   Piubello, Q ^b   Cordiano, C ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b BORGO TRENTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CELL; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; ITALY; LYMPH NODE METASTASIS; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PERITONEUM CANCER; PERITONEUM LAVAGE; POSTOPERATIVE COMPLICATION; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEROSA; SEX; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME;

AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; ITALY; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33645569726     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7901-2     Document Type: Article

References (30)

1. Marrelli D, Roviello F, de Manzoni G, et al, for the Italian Research Group for Gastric Cancer (IRGGC). Different patterns of recurrence in gastric cancer depending on Lauren histological type: a longitudinal study. World J Surg 2002;26:1160-1165.
2. Nakajima T, Harashima S, Hirata M, et al. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 1978;22:225-229.
3. Iitsuka Y, Kaneshima S, Tanida O, et al. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476-1480.
4. Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-262.
5. Abe S, Yoshimura H, Tabara H, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 1995;59:226-229.
6. Hermanek P, Sobin LJ. UICC TNM Classification of Malignant Tumors, 4th ed., 2nd rev, Berlin, Springer-Verlag, 1992.
7. Lauren P. The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
8. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies, Chichester, UK, John Wiley & Sons, 1995.
9. Ohno S, Maehara Y, Ohiwa H, et al. Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach. Semin Surg Oncol 1994;10:117-120.
10. Kaibara N, Iitsuka Y, Kimura A, et al. Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 1987;60:136-139.
11. Maehara Y, Kabashima A, Tokunaga E, et al. Recurrences and tumor growth potential and local immune response in gastric node-negative advanced gastric cancer. Oncology 1999;56:322-327.
12. Haraguchi M, Watanabe A, Kakeji Y, et al. Prognostic significance of serosal invasion in carcinoma of the stomach. Surg Gynecol Obstet 1991;172:29-32.
13. Boku Y, Nakane Y, Minoura T, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436-439.
14. Bonenkamp JJ, Songun I, Hermans J, et al. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996;83:672-674.
15. Schott A, Vogel I, Krueger U, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;3:372-379.
16. Suzuki T, Ochiai T, Hayashi H, et al. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Jpn J Surg 1999;29:111-115.
17. Hayes N, Wayman J, Wadehra V, et al. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 1999;79:520-524.
18. Burke EC, Karpeh MS, Conlon KC, et al. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998;5:411-415.
19. Boku Y, Nakane Y, Minoura T, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436-439.
20. Benevolo M, Mottolese M, Cosimelli M, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 1998;16:3406-3411.
21. Nekarda H, Geß C, Stark M, et al. Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma. Br J Cancer 1999;79:611-619.
22. Asao T, Fukuda T, Yazawa S, et al. Carcinoembryonic antigen levels in peritoneal washing can predict peritoneal recurrence after curative resection of gastric cancer. Cancer 1991;68:44-47.
23. Nishiyama M, Takashima I, Tanaka T, et al. Carcinoembryonic antigen levels in peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 1995;19:133-137.
24. Bold RJ, Ota DM, Ajani JA, et al. Peritoneal and serum tumour markers predict recurrence and survival of patients with resectable gastric cancer. Gastric Cancer 1999;2:1-7.
25. Fujimura T, Ohta T, Kitagawa H, et al. Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 1998;69:71-75.
26. Kodera Y, Nakanishi H, Yamamura Y, et al. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 1998;79:429-433.
27. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of the isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
28. Wittekind Ch, Henson DE, Hutter RVP, et al. TNM Supplement, 2nd Edition, Wiley-Liss; New York, 2001.
29. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-891.
30. Hirose K, Katayama K, Iida A, et al. Efficacy of continous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 1999;57:106-114.